Bulletin
Investor Alert

Cyclo Therapeutics Inc.

NAS: CYTH

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Jan 28, 2022, 4:00 p.m.

/zigman2/quotes/207006339/composite

$

3.63

Change

+0.06 +1.68%

Volume

Volume 30,264

Quotes are delayed by 20 min

/zigman2/quotes/207006339/composite

Previous close

$ 3.57

$ 3.63

Change

+0.06 +1.68%

Day low

Day high

$3.53

$3.75

Open

52 week low

52 week high

$3.40

$17.75

Open

Insider Actions for Cyclo Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/25/2020 Joshua M. Fine
Chief Financial Officer
15,000   Acquisition at $0.08 per share. 1,200
11/23/2020 Joshua M. Fine
Chief Financial Officer
10,000   Acquisition at $0.08 per share. 800
09/30/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/30/2020 Armistice Capital LLC
5,500   Disposition at $0.13 per share. 715
09/29/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/29/2020 Armistice Capital LLC
5,000   Disposition at $0.14 per share. 700
09/28/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/28/2020 Armistice Capital LLC
4,966   Disposition at $0.13 per share. 645
09/24/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/24/2020 Armistice Capital LLC
38,257   Disposition at $0.13 per share. 4,973
09/23/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/23/2020 Armistice Capital LLC
50,000   Disposition at $0.14 per share. 7,000
09/22/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/22/2020 Armistice Capital LLC
17,000   Disposition at $0.15 per share. 2,550
09/21/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/21/2020 Armistice Capital LLC
100,000   Disposition at $0.15 per share. 15,000
09/16/2020 Armistice Capital LLC
0   Disposition at $0 per share. 0
09/16/2020 Armistice Capital LLC
125,000   Disposition at $0.16 per share. 20,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
0 Purchases
0 Sales
0
0

Officers and Executives

Mr. Nathan Scott Fine
Chief Executive Officer & Director
Dr. Jeffrey L. Tate
Director, Chief Operating & Quality Officer
Mr. Joshua M. Fine
Chief Financial Officer & Secretary
Dr. Lise Lund Kjems
Chief Medical Officer
Dr. Sharon Hrynkow
Chief Scientific Officer & SVP-Medical Affairs
Mr. Russ Belden
Chief Commercial Officer
Ms. Lori McKenna Gorski
Global Head-Patient Advocacy
Mr. F. Patrick Ostronic
Vice Chairman
Mr. Michael Lisjak
Chief Regulatory Officer
Mr. Markus Walter Sieger
Chairman
Mr. Charles E. Rick Strattan
Independent Director
Mr. William S. Shanahan
Independent Director
Dr. Randall M. Toig
Independent Director
Link to MarketWatch's Slice.